Tumor Cell Isolation
Tumor Cell Isolation - Related Videos
10:15
Isolation and Culture Expansion of Tumor-specific Endothelial Cells
0 Views •
Cited by 20 •
2015
We report a reliable method to isolate and culture primary tumor-specific endothelial cells from genetically engineered mouse models.
Isolation of Immune Cells from Primary Tumors
0 Views •
Cited by 18 •
2012
In this report, we describe a protocol for isolating highly purified populations of leukocytes that infiltrate tumors. This protocol is adapted from the Miltenyi Biotech protocol to enhance yield and purity for isolating cells from complex tumor tissue.
03:14
PDAC Stem Cell Isolation: A Method to Isolate Cancer Stem Cells from Pancreatic Tumors
0 Views •
2023
This article describes the technique for isolating pancreatic cancer stem cells (CSCs) from human pancreatic ductal adenocarcinoma (PDAC) tissue. These CSCs are used to study the functional effects of drug treatment on the in vitro self-renewal capacity of CSCs for developing more efficient cancer treatments.
06:18
Isolating Tumor-Infiltrating Immune Cells from a Murine Brain
0 Views •
2025
The video demonstrates the isolation of tumor-infiltrating peripheral blood mononuclear cells from a mouse brain using mechanical dissociation and enzymatic digestion. This is followed by density gradient centrifugation to collect the immune cells for further analysis.
06:31
Primary Tumor and MEF Cell Isolation to Study Lung Metastasis
0 Views •
Cited by 13 •
2015
The goal of this protocol is to study breast tumorigenesis. With this technique, mouse mammary tumors are removed and primary cells are prepared from tumors. A lung extraction protocol is included for studying lung metastasis. Furthermore, another protocol for analyzing mouse embryonic fibroblasts from the mouse embryo is included.
FAQs
Mechanical disruption breaks tumor tissue into smaller components, while enzymatic dissociation helps separate cells from the tissue structure. Using both approaches supports recovery of individual cells rather than studying only intact tissue fragments. The balance between these steps can influence which cellular populations remain represented, making it important when investigating tumor heterogeneity or comparing cellular responses.
These properties provide different ways to distinguish tumor cells from surrounding biological material or from one another. Selection based on cell-surface markers emphasizes molecular identity, whereas size and density provide physical criteria; attachment behavior reflects how cells interact with a culture surface. The chosen property determines which population becomes enriched and can shape downstream findings.
Tumors contain diverse cell populations that may differ in gene expression, interactions, and treatment responses. An isolation strategy that enriches only one subset can therefore provide a focused view but may not represent the full tumor population. Examining defined populations alongside heterogeneity helps researchers relate specific cellular characteristics to invasion, recurrence, or therapeutic outcomes.
Isolation from brain or other nervous-system tumors creates a cellular system for examining how tumor cells interact with neural environments. Researchers can analyze tumor-associated gene expression, cellular heterogeneity, and neural interactions in a more defined population. These studies connect properties of nervous-system tumors with disease mechanisms and may clarify how cellular behavior relates to treatment response.
The workflow begins with tumor tissue or associated biological material, followed by mechanical and enzymatic dissociation to generate individual cells. Researchers then enrich or select the resulting population using surface markers, size, density, or attachment behavior. The selected cells can subsequently be directed into culture, molecular assays, drug screening, or studies of invasion and recurrence.
Isolated cells provide material for several complementary investigations. In culture, researchers can examine cellular behavior; molecular assays can assess gene expression; and drug screening can compare treatment responses. The same approach also supports studies of invasion and recurrence, allowing cellular observations to be connected with broader disease mechanisms and potential therapeutic outcomes.